AI-guided versus conventional physiotherapy follow-up for people treated for oral cancer
Official title: Effects of AI Based Physiotherapy on Mandibular Mobility Shoulder Function Whole Body Physical Function Quality of Life and Return to Work in Oral Cancer Patients: 3- and 9-Month Postintervention Follow-Up
Run by National Taiwan University Hospital · NCT07237672 · Data updated 2026-11-12
This follow-up will see if benefits from AI-guided physiotherapy compared with standard physiotherapy for people treated for oral cancer last at 3 and 9 months after the original intervention.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years to 70 Years |
| Sex | All |
| Enrollment | 65 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | December 6, 2025 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | December 16, 2025 |
| Trial ID | NCT07237672 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 20–65 who completed the original intervention, have no cancer recurrence or new conflicting treatments, and can attend in-person follow-up visits at 3 and 9 months.
✕Probably not a fit
Patients who experienced cancer recurrence, began new cancer treatments that affect function, withdrew from the original intervention, or cannot attend follow-up visits are unlikely to benefit from this follow-up evaluation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This continuation enrolls patients who completed the prior intervention phase and performs follow-up assessments at 3 and 9 months without delivering new treatments. Participants are grouped by their original allocation (AI-based physiotherapy or conventional physiotherapy) and undergo measurements of mandibular mobility, shoulder range of motion, functional performance, quality of life, pain, and return-to-work status. The protocol aims to determine whether short-term gains observed previously are maintained and whether they translate into meaningful long-term functional and vocational outcomes. All assessments are conducted at the National Taiwan University clinical site.
Why it matters
Potential benefit: If successful, the follow-up could show that AI-based physiotherapy leads to longer-lasting improvements in mouth opening, shoulder function, pain, and quality of life, potentially helping patients resume work sooner.
How similar studies have gone: The original short-term trial by the same group reported effects of AI-based physiotherapy, but long-term durability of those effects in oral cancer patients remains relatively novel and not widely established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants who completed the intervention phase of the previous trial (202411044RINC) * Age 20-65 years * Able to attend follow-up assessments at 3 and 9 months Exclusion Criteria: * Withdrawal from the original trial * Cancer recurrence or new cancer-related treatment interfering with functional assessment * Unable to communicate or comply with follow-up visits
Where it's running
-
School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Yueh-Hsia Chen, Ph.D. — National Taiwan University, College of Medicine
- Study coordinator: Yueh-Hsia Chen, Ph.D.
- Email: yuehhsiachen@ntu.edu.tw
- Phone: +886-2-33668133
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intratumoral fluorescent nivolumab before surgery in head and neck cancer
This study tests injecting fluorescently labeled nivolumab directly into head and neck tumors to see if it is safe and whether it reaches nearby lymph nodes before surgical removal.
-
AI-assisted prehabilitation to help oral cancer patients return to work
This trial will test an AI-assisted prehabilitation program to help adults with oral cancer reduce physical and emotional problems and return to work.
-
AI tool to measure jaw, neck, and shoulder movement for oral cancer care
This project tests an AI system that automatically measures jaw, neck, and shoulder movement for people with or recovering from oral cancer and compares its readings to manual measurements.
-
Dezocine versus nalbuphine with sufentanil for pain control after oral cancer surgery with free-flap reconstruction
This will see if adding dezocine or nalbuphine to sufentanil reduces pain and complications for adults undergoing oral cancer surgery with free-flap reconstruction.
-
Hydrogen water oral care after free flap reconstruction for oral cancer
A randomized trial tests whether hydrogen water oral care helps reduce inflammation and pain and improve oral bacteria after surgery for oral cancer.
-
Monitoring circulating tumor cells in postoperative ENE-positive oral cavity cancer after adjuvant concurrent chemoradiation.
This trial will test whether regular blood monitoring of circulating tumor cells and adding extended low-dose oral chemotherapy can help people with ENE-positive oral cavity squamous cell carcinoma after surgery and adjuvant concurrent chemoradiation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.